Skip to main content

Peer Review reports

From: Effectiveness and safety of adalimumab in patients with intestinal Behçet’s disease: a real-world prospective observational study in South Korea

Original Submission
3 Feb 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
17 Jul 2023 Author responded Author comments - Jae Hee Cheon
Resubmission - Version 3
17 Jul 2023 Submitted Manuscript version 3
21 Jul 2023 Author responded Author comments - Jae Hee Cheon
Resubmission - Version 4
21 Jul 2023 Submitted Manuscript version 4
1 Aug 2023 Reviewed Reviewer Report
26 Sep 2023 Reviewed Reviewer Report
10 Oct 2023 Author responded Author comments - Jae Hee Cheon
Resubmission - Version 5
10 Oct 2023 Submitted Manuscript version 5
18 Oct 2023 Author responded Author comments - Jae Hee Cheon
Resubmission - Version 6
18 Oct 2023 Submitted Manuscript version 6
20 Oct 2023 Reviewed Reviewer Report
29 Nov 2023 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
12 Dec 2023 Editorially accepted
19 Dec 2023 Article published 10.1186/s12876-023-03090-x

You can find further information about peer review here.

Back to article page